Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. Leonardi
541 Evaluation of Optimal Psoriasis Assessment Tool (OPAT) Incorporating Both Clinical and Patient-Reported Outcomes for Treatment of Moderate-To-Severe Plaque Psoriasis
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
阿达木单抗在斑块型银屑病成人患者中的长期安全性
British Journal of Dermatology
Dermatology
Medicine
Efficacy and Safety of Mirikizumab (LY3074828) in the Treatment of Moderate-To-Severe Plaque Psoriasis: Results From a Randomised Phase 2 Study
British Journal of Dermatology
Dermatology
Medicine
060 Integrated Safety of Ixekizumab in Patients With Moderate-To-Severe Psoriasis: Results From a Pooled Analysis of 7 Clinical Trials
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
540 Rapid Response in PASI, sPGA, and BSA Measures for Patients With Moderate-To-Severe Plaque Psoriasis With Ixekizumab
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Long-Term Safety of Adalimumab in Adult Patients With Plaque Psoriasis
British Journal of Dermatology
Dermatology
Medicine
713 the Association Between Disease Severity at Time of Retreatment and Probability of Recapture in Psoriasis Patients Receiving Ixekizumab
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
059 Ixekizumab Shows No Association With MACE in Patients With Moderate-To-Severe Psoriasis: An Integrated Safety Analysis of Clinical Trials
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Contexte Initial De Prise en Charge, Qualité De Vie À 3mois Et Survie Des Patients Dialysés Pour Insuffisance Rénale Chronique Terminale Dans Deux Départements Français D’Amérique
Nephrologie et Therapeutique
Nephrology
